Kisspeptin

A hypothalamic peptide that triggers gonadotrophin release, studied in human reproductive endocrinology.

What research shows

Kisspeptin has genuine randomized human research behind it: controlled administration studies measuring gonadotrophin responses, and brain imaging trials examining sexual and emotional processing. It remains a research and diagnostic tool. No approved product was found, and long-term safety data does not exist.

Evidence strength

Highest evidence grade among the graded claims: B. Grades reflect study strength, not benefit.

Safety context

See the safety section. Absence of a flag is not evidence of safety.

No endorsement

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.